Mersana Therapeutics Inc (MRSN)
2.225
+0.08
(+3.97%)
USD |
NASDAQ |
Jun 10, 16:00
2.225
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Price: 2.225 for June 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Jun 07, 2024 | 2.20 | 2.24 | 2.105 | 2.14 | 967205.0 |
Jun 06, 2024 | 2.33 | 2.37 | 2.20 | 2.215 | 981430.0 |
Jun 05, 2024 | 2.20 | 2.35 | 2.17 | 2.31 | 2.969M |
Jun 04, 2024 | 2.34 | 2.38 | 2.19 | 2.20 | 1.288M |
Jun 03, 2024 | 2.39 | 2.515 | 2.305 | 2.35 | 5.685M |
May 31, 2024 | 2.45 | 2.53 | 2.325 | 2.33 | 669923.0 |
May 30, 2024 | 2.38 | 2.435 | 2.33 | 2.40 | 807111.0 |
May 29, 2024 | 2.38 | 2.38 | 2.29 | 2.35 | 1.343M |
May 28, 2024 | 2.38 | 2.42 | 2.27 | 2.40 | 1.455M |
May 24, 2024 | 2.48 | 2.51 | 2.37 | 2.38 | 913270.0 |
May 23, 2024 | 2.57 | 2.58 | 2.37 | 2.47 | 1.732M |
May 22, 2024 | 2.63 | 2.710 | 2.55 | 2.57 | 679207.0 |
May 21, 2024 | 2.76 | 2.79 | 2.51 | 2.62 | 1.567M |
May 20, 2024 | 2.71 | 2.78 | 2.675 | 2.77 | 838601.0 |
May 17, 2024 | 2.60 | 2.78 | 2.49 | 2.73 | 2.505M |
May 16, 2024 | 2.57 | 2.63 | 2.46 | 2.58 | 1.279M |
May 15, 2024 | 2.68 | 2.88 | 2.51 | 2.57 | 1.892M |
May 14, 2024 | 2.67 | 2.72 | 2.45 | 2.61 | 5.347M |
May 13, 2024 | 2.76 | 2.78 | 2.60 | 2.62 | 2.239M |
May 10, 2024 | 2.61 | 2.73 | 2.47 | 2.71 | 2.807M |
May 09, 2024 | 3.49 | 3.50 | 2.46 | 2.465 | 3.772M |
May 08, 2024 | 3.46 | 3.525 | 3.32 | 3.40 | 876321.0 |
May 07, 2024 | 3.55 | 3.63 | 3.49 | 3.525 | 679630.0 |
May 06, 2024 | 3.52 | 3.59 | 3.46 | 3.50 | 694529.0 |
May 03, 2024 | 3.52 | 3.63 | 3.42 | 3.46 | 1.189M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.06
Minimum
Aug 02 2023
27.59
Maximum
Dec 23 2020
8.355
Average
6.05
Median
Dec 21 2022
Price Benchmarks
Amicus Therapeutics Inc | 10.06 |
Insmed Inc | 59.84 |
Altimmune Inc | 6.255 |
InfuSystems Holdings Inc | 6.90 |
Anavex Life Sciences Corp | 3.78 |
Price Related Metrics
PS Ratio | 6.946 |
Price to Book Value | 9.729 |
Earnings Yield | -51.24% |
Market Cap | 272.25M |